[When research and clinical recommendations are (temporarily) in contradiction: the evaluation of lung cancer screening for high-risk subjects in Europe and in the USA].


Lung cancer is the first cancer mortality cause in Italy. In last decades, incidence rates have been falling down, but the annual number of deaths is stable because of population ageing. Survival rates for population-based lung cancer cases were at maximum 17% in the last decades. In 2011, the National Lung Screening Trial (NLST) has published the results… (More)
DOI: 10.19191/EP16.1S1.P035.028


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics